Skip to main content
. Author manuscript; available in PMC: 2013 Nov 15.
Published in final edited form as: J Neuroimmunol. 2012 Aug 29;252(1-2):106–112. doi: 10.1016/j.jneuroim.2012.08.006

Table 2.

Characteristics of patients with and without white matter disease. Data are presented at the proportion or the median (interquartile range). Statistics are by Mann-Whitney U test or χ2 as appropriate.

Fazekas ≤2
N=88
Fazekas ≥3
N=22
P
demographics
age 52 (42, 64) 68 (61–73) <0.001
female 31/88 (35%) 6/22 (27%) NS
Caucasian 78/88 (89%) 21/22 (95%) NS
atrial fibrillation 11/88 (12%) 4/22 (18%) NS
hypertension 42/88 (48%) 16/22 (73%) 0.036
smoker 38/88 (43%) 5/22 (23%) 0.079
coronary heart disease 19/88 (22%) 6/22 (27%) NS
diabetes 21/88 (24%) 6/22 (27%) NS
characteristics of presenting stroke
NIHSS 10 (3, 19) 10 (4, 18) NS
total infarct volume (cc) 15.2 (1.5, 94.8) 5.2 (0.5, 55.5) NS
hemorrhagic conversion (any) 18/88 (20%) 4/22 (18%) NS
prior infarct on imaging* 16/88 (18%) 10/22 (45%) 0.007
treatment
endovascular intervention 13/88 (15%) 1/22 (4%) 0.198
IV tPA 19/88 (22%) 7/22 (32%) NS
hemicraniectomy 7/88 (8%) 1/22 (4%) NS
stroke etiology
lacunar 6/88 (7%) 5/22 (23%) 0.026
cardioembolic 23/88 (26%) 6/22 (27%) NS
large vessel disease 15/88 (17%) 2/22 (9%) NS
dissection 6/88 (7%) 0/22 NS
other 25/88 (28%) 4/22 (18%) NS
unknown 19/88 (22%) 5/22 (23%) NS
stroke related complications
infection by day 15 20/87 (23%) 6/22 (27%) NS
pneumonia by day 15 8/87 (9%) 3/22 (14%) NS

NIHSS = National Institutes of Health Stroke Scale Score, IV tPA = intravenous tissue plasminogen activator,

*

signifies a radiological infarct, NS= not significant and signifies P≥0.200.